Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
SpyGlass Pharma(SGP.US) Listed on the US stock market, opening with a surge of over 43%
On Friday, SpyGlass Pharma (SGP.US) launched on the U.S. stock market, with the opening stock price soaring over 43% to $23, compared to an IPO price of $16. SpyGlass Pharma is a late-stage clinical biotechnology company focused on developing sustained drug delivery systems for chronic eye diseases, aiming to improve patients’ vision and quality of life through longer-lasting and sustainable treatment options. Its core R&D product includes a system that combines a drug delivery pad with an artificial lens, used to treat chronic eye conditions such as open-angle glaucoma or high intraocular pressure. These treatments aim to enhance efficacy and patient compliance, offering potential advantages over traditional daily eye drops.